🌅 Today's Morning Call
|
S&P Futures
7,513.25
▲ +10.75 (+0.14%)
|
Nasdaq Futures
30,151.50
▲ +48.50 (+0.16%)
|
Dow Futures
52,634.00
▲ +68.00 (+0.13%)
|
|
10Y Treasury
4.37%
▲ +0.00%
|
US Dollar
101.38
▲ +0.06 (+0.06%)
|
Bitcoin
$58,968
▼ -$1,194 (-1.98%)
|
👀 What to Watch Today
Today wraps up the second quarter, which means portfolio rebalancing flows will be a real factor throughout the session. Large institutional funds will be adjusting positions to align with quarter-end targets, and that can create unusual volume and price swings in both directions. Keep an eye on broader index moves that may not perfectly reflect the underlying news.On the economic data front, watch for any final reads on consumer spending or manufacturing data that could influence the Fed narrative heading into July. The 10-year Treasury is sitting steady at 4.37%, signaling the bond market is not particularly alarmed by anything on today's calendar.
AbbVie (ABBV) is worth monitoring closely given its partnership with Genmab (GMAB) and the positive lymphoma trial readout. Any analyst commentary or price target revisions flowing from this morning's headline could add momentum to both names during regular hours.
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🌏 Overnight Recap
European markets opened the session reacting to a significant policy move from the EU, which announced it will cap tariff-free steel imports and slap a 50% duty on any steel that comes in above the quota threshold. The measure takes effect Wednesday, and it is already rattling steel-adjacent sectors across the continent. European steelmakers broadly welcomed the news as a protective buffer against global overcapacity.In Asia, markets were mixed overnight with no single dominant theme driving direction. The dollar index (DXY) edged slightly higher to 101.38, keeping some pressure on commodities priced in USD. Bitcoin pulled back nearly 2% to around $58,968, continuing to drift without a strong near-term catalyst.
The biggest overnight headline stateside came from Genmab (GMAB), whose shares moved higher after the Danish biotech and its partner AbbVie (ABBV) announced their lymphoma drug combination hit its primary endpoint in a late-stage clinical trial. That is exactly the kind of data readout that can reprice a stock fast.
I Became a Millionaire Here While I Was Still in College
This little-known building in Pasadena is where I learned about a kind of investment most people never get access to. Twenty years later, that same opportunity is wide open again. And it's all because of what's about to happen to OpenAI and Anthropic.
📊 Pre-Market Movers
Genmab (GMAB) is the clear standout in pre-market action, with shares rising after the company and AbbVie (ABBV) confirmed their combination lymphoma therapy met its primary endpoint in a Phase 3 trial. Late-stage trial success is one of the most powerful catalysts in biotech, and this one lands cleanly. ABBV is worth watching too, as a commercial partner with real upside exposure to the eventual launch.On the macro side, steel-related names like Nucor (NUE) and Cleveland-Cliffs (CLF) are worth a look given the EU's tariff announcement. While the policy targets imports into Europe rather than the U.S., global steel trade dynamics are interconnected, and any supply rerouting could affect domestic pricing.
Beyond those specific movers, the broader pre-market picture is calm. S&P futures are up just 0.14%, Nasdaq is up 0.16%, and the Dow is tacking on 0.13%. This is not a rip-your-face-off kind of morning. It is a measured, watch-and-react setup.
🔍 Today's Watchlist
- GMAB and ABBV: Late-stage lymphoma trial success is a major de-risking event. Watch for volume and analyst upgrades at the open.
- Steel sector names: The EU's new import quota and 50% tariff above threshold could ripple into U.S. steelmakers like NUE and CLF.
- Q2 rebalancing flows: Quarter-end positioning by institutional funds may drive outsized moves in index heavyweights today.
- Treasury yields and the Fed: The 10-year holding at 4.37% is calm for now, but any data surprise today could shift the July rate outlook.
- Bitcoin at $58,968: Crypto is softening as the dollar firms. Watch whether BTC holds support or slips further ahead of the week's close.
While the whole world is watching Elon, the real money is moving somewhere else
When Elon Musk ran a Twitter poll in 2021, Tesla lost $30 billion in a single day.
When he changed the Twitter logo to Dogecoin, the coin surged 30% overnight.
No one alive moves markets the way Elon does.
Larry Benedict — the trader who delivered a 279% return on cash in 2025 — says Elon's next move is his biggest yet.
And there's ONE ticker, overlooked by almost everyone, positioned to capture it.
🎯 The Morning Playbook
The playbook for today is really two-track. First, treat any unusual volume early in the session with some skepticism, because quarter-end rebalancing can make price action look more dramatic than the fundamentals warrant. If a stock you are watching spikes or drops sharply at the open, give it a few minutes to settle before drawing conclusions.Second, lean into the stories that have real catalysts. GMAB and ABBV have fundamental news behind them, not just noise. And the EU steel story, while centered overseas, is worth tracking for second-order effects on U.S. producers and industrial suppliers.
As Q2 officially closes today, take a moment to assess where your positions stand relative to your original thesis. Markets have a way of rewarding those who stay clear-eyed at the end of a quarter rather than chasing the day's action.
📰 Further Reading
In February 2016, Nvidia was trading at $2.51, split-adjusted. The name barely came up in investment circles. But my data had flagged something. A pattern the market hadn't priced in yet. I sent my readers a single, clear recommendation. And anyone who acted could've got in on the biggest investment...
Click here now — before I'm forced to take it down.
Elon Musk wants to send you money. It's a free bonus if you sign up for his new bank. Lots of people are already flocking to the bank — including Star Trek star William Shatner.
Banking insider, Luke Lango, reveals how you can join them here — also the much bigger opportunity connected to this.
Trump called America's rare-earth dependence a "national emergency." But one potential breakthrough… quietly engineered by Elon Musk… could end that crisis forever. And one tiny company is sitting at the center of it all. Musk is expected to make an announcement any day now.
See more about this secret project here.